Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP583937.RAVLACMUuOygvQtO4dY82KBig61PKPDfdY0_JcTraFwqY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP583937.RAVLACMUuOygvQtO4dY82KBig61PKPDfdY0_JcTraFwqY130_assertion type Assertion NP583937.RAVLACMUuOygvQtO4dY82KBig61PKPDfdY0_JcTraFwqY130_head.
- NP583937.RAVLACMUuOygvQtO4dY82KBig61PKPDfdY0_JcTraFwqY130_assertion wasGeneratedBy ECO_0000203 NP583937.RAVLACMUuOygvQtO4dY82KBig61PKPDfdY0_JcTraFwqY130_provenance.
- NP583937.RAVLACMUuOygvQtO4dY82KBig61PKPDfdY0_JcTraFwqY130_assertion wasDerivedFrom befree-2016 NP583937.RAVLACMUuOygvQtO4dY82KBig61PKPDfdY0_JcTraFwqY130_provenance.
- NP583937.RAVLACMUuOygvQtO4dY82KBig61PKPDfdY0_JcTraFwqY130_assertion SIO_000772 17164332 NP583937.RAVLACMUuOygvQtO4dY82KBig61PKPDfdY0_JcTraFwqY130_provenance.
- NP583937.RAVLACMUuOygvQtO4dY82KBig61PKPDfdY0_JcTraFwqY130_assertion evidence source_evidence_literature NP583937.RAVLACMUuOygvQtO4dY82KBig61PKPDfdY0_JcTraFwqY130_provenance.
- NP583937.RAVLACMUuOygvQtO4dY82KBig61PKPDfdY0_JcTraFwqY130_assertion description "[We show that pazopanib is the first-in-class VEGF receptor inhibitor to inhibit in vivo tumor cell growth associated with increased MM cell apoptosis, decreased angiogenesis, and prolonged survival in a mouse xenograft model of human MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP583937.RAVLACMUuOygvQtO4dY82KBig61PKPDfdY0_JcTraFwqY130_provenance.